Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of SYS6088 in advanced or metastatic solid tumors
CTR20263928Phase 2Active
- Sponsor
- CSPC Megalith Biopharmaceutical Co., Ltd.
- Start
- Oct 2026
- Countries
- 1
01
Overview
A Phase 2 trial of SYS6088 in Nonhematologic neoplasms, sponsored by CSPC Megalith Biopharmaceutical Co., Ltd.. Started Oct 2026; status: active.
02
Drugs
SYS6088
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20263928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263928.